These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 21124990

  • 21. Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10.
    Rujas E, Gulzar N, Morante K, Tsumoto K, Scott JK, Nieva JL, Caaveiro JM.
    J Virol; 2015 Dec; 89(23):11975-89. PubMed ID: 26378169
    [Abstract] [Full Text] [Related]

  • 22. The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat.
    Montefiori DC, Filsinger Interrante MV, Bell BN, Rubio AA, Joyce JG, Shiver JW, LaBranche CC, Kim PS.
    Proc Natl Acad Sci U S A; 2021 Jan 19; 118(3):. PubMed ID: 33431684
    [Abstract] [Full Text] [Related]

  • 23. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
    Bryson S, Julien JP, Isenman DE, Kunert R, Katinger H, Pai EF.
    J Mol Biol; 2008 Oct 17; 382(4):910-9. PubMed ID: 18692506
    [Abstract] [Full Text] [Related]

  • 24. Estimating the probability of polyreactive antibodies 4E10 and 2F5 disabling a gp41 trimer after T cell-HIV adhesion.
    Hu B, Liao HX, Alam SM, Goldstein B.
    PLoS Comput Biol; 2014 Jan 17; 10(1):e1003431. PubMed ID: 24499928
    [Abstract] [Full Text] [Related]

  • 25. Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies.
    Choudhry V, Zhang MY, Sidorov IA, Louis JM, Harris I, Dimitrov AS, Bouma P, Cham F, Choudhary A, Rybak SM, Fouts T, Montefiori DC, Broder CC, Quinnan GV, Dimitrov DS.
    Virology; 2007 Jun 20; 363(1):79-90. PubMed ID: 17306322
    [Abstract] [Full Text] [Related]

  • 26. Monoclonal antibodies that bind to the core of fusion-active glycoprotein 41.
    Chen CH, Greenberg ML, Bolognesi DP, Matthews TJ.
    AIDS Res Hum Retroviruses; 2000 Dec 10; 16(18):2037-41. PubMed ID: 11153086
    [Abstract] [Full Text] [Related]

  • 27. Generation of HIV-1 potent and broad neutralizing antibodies by immunization with postfusion HR1/HR2 complex.
    Dawood R, Benjelloun F, Pin JJ, Kone A, Chanut B, Jospin F, Lucht F, Verrier B, Moog C, Genin C, Paul S.
    AIDS; 2013 Mar 13; 27(5):717-30. PubMed ID: 23719346
    [Abstract] [Full Text] [Related]

  • 28. Unique binding modes for the broad neutralizing activity of single-chain variable fragments (scFv) targeting CD4-induced epitopes.
    Tanaka K, Kuwata T, Alam M, Kaplan G, Takahama S, Valdez KPR, Roitburd-Berman A, Gershoni JM, Matsushita S.
    Retrovirology; 2017 Sep 22; 14(1):44. PubMed ID: 28938888
    [Abstract] [Full Text] [Related]

  • 29. Construction and phenotypic characterization of HIV type 1 functional envelope clones of subtypes G and F.
    Revilla A, Delgado E, Christian EC, Dalrymple J, Vega Y, Carrera C, González-Galeano M, Ocampo A, de Castro RO, Lezaún MJ, Rodríguez R, Mariño A, Ordóñez P, Cilla G, Cisterna R, Santamaría JM, Prieto S, Rakhmanova A, Vinogradova A, Ríos M, Pérez-Álvarez L, Nájera R, Montefiori DC, Seaman MS, Thomson MM.
    AIDS Res Hum Retroviruses; 2011 Aug 22; 27(8):889-901. PubMed ID: 21226626
    [Abstract] [Full Text] [Related]

  • 30. Role of HIV membrane in neutralization by two broadly neutralizing antibodies.
    Alam SM, Morelli M, Dennison SM, Liao HX, Zhang R, Xia SM, Rits-Volloch S, Sun L, Harrison SC, Haynes BF, Chen B.
    Proc Natl Acad Sci U S A; 2009 Dec 01; 106(48):20234-9. PubMed ID: 19906992
    [Abstract] [Full Text] [Related]

  • 31. A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope.
    Miller MD, Geleziunas R, Bianchi E, Lennard S, Hrin R, Zhang H, Lu M, An Z, Ingallinella P, Finotto M, Mattu M, Finnefrock AC, Bramhill D, Cook J, Eckert DM, Hampton R, Patel M, Jarantow S, Joyce J, Ciliberto G, Cortese R, Lu P, Strohl W, Schleif W, McElhaugh M, Lane S, Lloyd C, Lowe D, Osbourn J, Vaughan T, Emini E, Barbato G, Kim PS, Hazuda DJ, Shiver JW, Pessi A.
    Proc Natl Acad Sci U S A; 2005 Oct 11; 102(41):14759-64. PubMed ID: 16203977
    [Abstract] [Full Text] [Related]

  • 32. Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane-proximal external region.
    Nicely NI, Dennison SM, Spicer L, Scearce RM, Kelsoe G, Ueda Y, Chen H, Liao HX, Alam SM, Haynes BF.
    Nat Struct Mol Biol; 2010 Dec 11; 17(12):1492-4. PubMed ID: 21076400
    [Abstract] [Full Text] [Related]

  • 33. Sequestering of the prehairpin intermediate of gp41 by peptide N36Mut(e,g) potentiates the human immunodeficiency virus type 1 neutralizing activity of monoclonal antibodies directed against the N-terminal helical repeat of gp41.
    Gustchina E, Bewley CA, Clore GM.
    J Virol; 2008 Oct 11; 82(20):10032-41. PubMed ID: 18667502
    [Abstract] [Full Text] [Related]

  • 34. Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function.
    Guenaga J, Wyatt RT.
    PLoS Pathog; 2012 Oct 11; 8(7):e1002806. PubMed ID: 22829767
    [Abstract] [Full Text] [Related]

  • 35. Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions.
    Neurath AR, Strick N, Lin K, Jiang S.
    AIDS Res Hum Retroviruses; 1995 Jun 11; 11(6):687-96. PubMed ID: 7576928
    [Abstract] [Full Text] [Related]

  • 36. Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses.
    Zhuang M, Vassell R, Yuan C, Keller PW, Ling H, Wang W, Weiss CD.
    J Virol; 2019 Jun 01; 93(11):. PubMed ID: 30894471
    [Abstract] [Full Text] [Related]

  • 37. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
    Duchemin M, Khamassi M, Xu L, Tudor D, Bomsel M.
    Front Immunol; 2018 Jun 01; 9():244. PubMed ID: 29651286
    [Abstract] [Full Text] [Related]

  • 38. Interactions between lipids and human anti-HIV antibody 4E10 can be reduced without ablating neutralizing activity.
    Xu H, Song L, Kim M, Holmes MA, Kraft Z, Sellhorn G, Reinherz EL, Stamatatos L, Strong RK.
    J Virol; 2010 Jan 01; 84(2):1076-88. PubMed ID: 19906921
    [Abstract] [Full Text] [Related]

  • 39. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
    Keller PW, Morrison O, Vassell R, Weiss CD.
    J Virol; 2018 Aug 15; 92(16):. PubMed ID: 29875245
    [Abstract] [Full Text] [Related]

  • 40. Molecular Basis of Unusually High Neutralization Resistance in Tier 3 HIV-1 Strain 253-11.
    Moyo T, Ereño-Orbea J, Jacob RA, Pavillet CE, Kariuki SM, Tangie EN, Julien JP, Dorfman JR.
    J Virol; 2018 Jul 15; 92(14):. PubMed ID: 29618644
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.